Literature DB >> 8828497

Heparin inhibition of insulin-like growth factor-binding protein-3 binding to human fibroblasts and rat glioma cells: role of heparan sulfate proteoglycans.

Y W Yang1, M Yanagishita, M M Rechler.   

Abstract

The mitogenic action of insulin-like growth factors (IGFs) on target cells is determined by interaction with signaling IGF-I receptors and modulated by interactions with IGF-binding proteins (IGFBPs). IGFBP-3, an abundant IGFBP that binds IGF-I and IGF-II with high affinity, can form soluble inhibitory complexes with the IGFs that prevent them from binding to IGF-I receptors. Alternatively, IGFBP-3 can bind to the cell surface and possibly potentiate IGF action or act independently of the IGFs. Previous studies showed that heparin inhibited IGFBP-3 binding to the cell surface and increased its accumulation in the medium, suggesting that it might act as a competitive inhibitor of IGFBP-3 binding to structurally similar heparan sulfate proteoglycans on the cell surface. We evaluated this hypothesis by binding 125I-labeled recombinant glycosylated human IGFBP-3 to human fetal skin fibroblasts (GM-10) and to C6 rat glioma cells at 12 C. Heparin inhibited [125I]IGFBP-3 binding more effectively than chondroitin sulfate and dextran sulfate. Complete digestion of cell surface heparan sulfate and chondroitin sulfate glycosaminoglycans using heparitinase and chondroitinase ABC, however, did not significantly decrease IGFBP-3 binding. Quantitative removal was demonstrated by analysis of parallel cultures of cells whose glycosaminoglycans had been biosynthetically labeled using Na2 35SO4. These results suggested that IGFBP-3 did not bind to heparan sulfate glycosaminoglycans on the cell surface, and that the inhibition of IGFBP-3 binding by heparin most likely resulted from its direct interaction with the heparin-binding domains of IGFBP-3. When [125I]IGFBP-3 was incubated with GM-10 fibroblasts or C6 glioma cells at 37 C for 4 h, only 10% of the bound ligand remained associated with the cell surface; approximately 90% of the cell-associated radio-activity was internalized and could be recovered in lysates of acid-washed cells. Incubation with IGF-I or heparin decreased the total cell-associated radioactivity, but did not affect internalization. These results suggest that direct interaction of heparin or IGF-I with IGFBP-3 inhibits its ability to bind to the surface of GM-10 fibroblasts and C6 glioma cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8828497     DOI: 10.1210/endo.137.10.8828497

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

Review 1.  Cellular actions of insulin-like growth factor binding proteins.

Authors:  R J Ferry; L E Katz; A Grimberg; P Cohen; S A Weinzimer
Journal:  Horm Metab Res       Date:  1999 Feb-Mar       Impact factor: 2.936

Review 2.  Genetics, chemistry, and function of the IGF/IGFBP system.

Authors:  P F Collett-Solberg; P Cohen
Journal:  Endocrine       Date:  2000-04       Impact factor: 3.633

Review 3.  Insulin like growth factor-1 and insulin-like growth factor binding proteins: their possible roles in both maintaining normal retinal vascular function and in promoting retinal pathology.

Authors:  Lynn C Shaw; Maria B Grant
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

4.  Insulin-like growth factor-binding protein-2 is required for osteoclast differentiation.

Authors:  Victoria E DeMambro; Laura Maile; Christine Wai; Masanobu Kawai; Teresa Cascella; Clifford J Rosen; David Clemmons
Journal:  J Bone Miner Res       Date:  2012-02       Impact factor: 6.741

5.  Muscle reinnervation and IGF-I synthesis are affected by exposure to heparin: an effect partially antagonized by anti-growth hormone-releasing hormone.

Authors:  Laura Madaschi; Anna Maria Di Giulio; Alfredo Gorio
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

Review 6.  Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis.

Authors:  A Grimberg; P Cohen
Journal:  J Cell Physiol       Date:  2000-04       Impact factor: 6.384

7.  Induction of apoptosis in human prostate cancer cells by insulin-like growth factor binding protein-3 does not require binding to retinoid X receptor-alpha.

Authors:  Giovanna Zappala; Cem Elbi; Joanna Edwards; Julie Gorenstein; Matthew M Rechler; Nisan Bhattacharyya
Journal:  Endocrinology       Date:  2007-12-27       Impact factor: 4.736

8.  Biochemical determinants of the IGFBP-3-hyaluronan interaction.

Authors:  Sadaf Dorandish; Jonathan Devos; Bradley Clegg; Deanna Price; Robert Muterspaugh; Jeffrey Guthrie; Deborah L Heyl; Hedeel Guy Evans
Journal:  FEBS Open Bio       Date:  2020-07-22       Impact factor: 2.693

Review 9.  Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3): Unraveling the Role in Mediating IGF-Independent Effects Within the Cell.

Authors:  Shailly Varma Shrivastav; Apurva Bhardwaj; Kumar Alok Pathak; Anuraag Shrivastav
Journal:  Front Cell Dev Biol       Date:  2020-05-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.